Evidence map›Paper›PMID 39002003›Full record

ArticleMolecular biology reports2024

Up-regulation of miR-126 via DNA methylation in hypoxia-preconditioned endothelial cells may contribute to hypoxic tolerance of neuronal cells.

Pu Zhang, Gang Fu, Wenqing Xu, Kerui Gong, Zhujun Zhao, Kai Sun, Chunyang Zhang, Ruijuan Han, Guo Shao

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. MicroRNA-126 as an endogenous molecule for hypoxic/ischemic tolerance in neuroprotection.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pu Zhang *Center for Translational Medicine, the Third People's Hospital of Longgang District, Shenzhen, PR China.
Gang Fu *Department of Cardiology, the Third People's Hospital of Longgang District, Shenzhen, PR China.
Wenqing Xu *Inner Mongolia Key Laboratory of Hypoxic Translational Medicine, Baotou, PR China.
Kerui GongDepartment of Oral and Maxillofacial Surgery, Department of Neurosurgery, University of California San Francisco, San Francisco, USA.
Zhujun ZhaoDepartment of Neurosurgery, The First Affiliated Hospital of Baotou Medical College, Baotou, PR China.
Kai SunCenter for Translational Medicine, the Third People's Hospital of Longgang District, Shenzhen, PR China.
Chunyang ZhangDepartment of Neurosurgery, The First Affiliated Hospital of Baotou Medical College, Baotou, PR China. zhangchunyangbyyfy@163.com.
Ruijuan HanDepartment of Cardiology, the Third People's Hospital of Longgang District, Shenzhen, PR China. ruijuanhan@163.com.
Guo ShaoCenter for Translational Medicine, the Third People's Hospital of Longgang District, Shenzhen, PR China. shao.guo.china@gmail.com.

Funding

National Natural Science Foundation of China 81660307, 82060337
6 · The paper itself

Abstract

backgroundEndothelial cells (ECs) can confer neuroprotection by secreting molecules. This study aimed to investigate whether DNA methylation contributes to the neuroprotective gene expression induced by hypoxia preconditioning (HPC) in ECs and to clarify that the secretion of molecules from HPC ECs may be one of the molecular mechanisms of neuroprotection.

methodsHuman microvascular endothelial cell-1 (HMEC-1) was cultured under normal conditions (C), hypoxia(H), and hypoxia preconditioning (HPC), followed by the isolation of culture medium (CM). SY5Y cell incubated with the isolated CM from HMEC-1 was exposed to oxygen-glucose deprivation (OGD). The DNA methyltransferases (DNMTs), global methylation level, miR-126 and its promotor DNA methylation level in HMEC-1 were measured. The cell viability and cell injury in SY5Y were detected.

resultsHPC decreased DNMTs level and global methylation level as well as increased miR-126 expression in HMEC-1. CM from HPC treated HMEC-1 also relieved SY5Y cell damage, while CM from HMEC-1 which over-expression of miR-126 can reduce injury in SY5Y under OGD condition.

conclusionsThese findings indicate EC may secrete molecules, such as miR-126, to execute neuroprotection induced by HPC through regulating the expression of DNMTs.

Indexed as

Cell HypoxiaDNA MethylationEndothelial CellsMicroRNAsNeuronsApoptosisCell LineCell SurvivalGlucoseOxygenPromoter Regions, GeneticUp-RegulationGlucoseMicroRNAsMIRN126 microRNA, humanOxygenCulture mediumEndothelial cellsHypoxic preconditioningNeuroprotection

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.